NCT03524729

Brief Summary

Ankle osteoarthritis (OA) is a painful, progressive condition that can severely limit physical activity and reduce quality of life. Rocker bottom (RB) shoes and ankle-foot orthoses (AFOs) are commonly used as non-surgical treatments for ankle OA. RB shoes have a curved sole in the toe to heel direction that may alleviate joint pain by reducing ankle range of motion (ROM). Similarly, AFOs may reduce joint motion by securing the foot and ankle within the ankle-foot orthosis (AFO) frame. This study aims to determine the ability of RB shoes and AFOs to improve mobility, by relieving pain and reducing joint ROM.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 29, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 15, 2018

Completed
8 months until next milestone

Study Start

First participant enrolled

January 1, 2019

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2023

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

September 19, 2024

Completed
Last Updated

September 19, 2024

Status Verified

August 1, 2024

Enrollment Period

3.4 years

First QC Date

March 29, 2018

Results QC Date

June 21, 2023

Last Update Submit

August 13, 2024

Conditions

Keywords

Rocker bottom shoeAnkle-foot orthosisAnkle osteoarthritis

Outcome Measures

Primary Outcomes (1)

  • Daily Step Count (# Steps)

    The daily step count of a participant as measured by a body worn pedometer.

    Three weeks

Secondary Outcomes (11)

  • Ankle Joint Range of Motion (Degrees)

    Three weeks

  • Self-selected Walking Speed

    Three weeks

  • Qualitative Assessment of Patient Device Wearing

    Three weeks

  • Patient Reported Outcomes Measurement Information System (PROMIS) Physical Function

    three weeks

  • Fast Walking Speed

    Three weeks

  • +6 more secondary outcomes

Study Arms (2)

Ankle osteoarthritis patients

ACTIVE COMPARATOR

Ambulatory adult patients (18+) with ankle osteoarthritis.

Device: Rocker bottom shoeDevice: Ankle foot orthosisDevice: Standard walking shoe

Healthy control subjects

OTHER

Ambulatory adults (18+) with no known ankle osteoarthritis.

Device: Standard walking shoe

Interventions

Walking shoe with a anterior posterior rocker sole.

Ankle osteoarthritis patients

Dynamic carbon fiber ankle brace.

Ankle osteoarthritis patients

Standard walking shoe (control shoe) with no rocker sole.

Ankle osteoarthritis patientsHealthy control subjects

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • For osteoarthritis patients:
  • radiographic evidence of tibiotalar osteoarthritis
  • ambulatory
  • For healthy controls:
  • ambulatory
  • aged 18 or older

You may not qualify if:

  • For osteoarthritis patients and healthy controls:
  • subtalar joint arthritis
  • plans for surgical treatment of ankle osteoarthritis within the next 4 months
  • surgical, neurological, metabolic, or lower limb musculoskeletal problem that would impair study measures
  • inability to walk unassisted during short, repeated walking trials
  • rheumatoid arthritis
  • inadequate cognitive or language function to consent or to participate
  • no phone number or stable mailing address

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA Puget Sound Health Care System Seattle Division, Seattle, WA

Seattle, Washington, 98108, United States

Location

Results Point of Contact

Title
Dr. Sangeorzan
Organization
VA

Study Officials

  • Bruce J. Sangeorzan, MD

    VA Puget Sound Health Care System Seattle Division, Seattle, WA

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Masking Details
No masking
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: The osteoarthritis participants will wear the control shoe, rocker bottom shoe, and AFO for multiple weeks each. The order of the treatments (control shoe, rocker bottom shoe, and AFO) will be randomize. The control group will only wear the control shoe.
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 29, 2018

First Posted

May 15, 2018

Study Start

January 1, 2019

Primary Completion

June 1, 2022

Study Completion

June 15, 2023

Last Updated

September 19, 2024

Results First Posted

September 19, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will share

All individual participant data collected will be de-identified and placed in publically accessible online data repositories.

Time Frame
Data will be posted ad-hoc on an ongoing basis.
Access Criteria
Once posted, the data is available to the public.

Locations